Randomised Clinical Trials of COVID-19 Vaccines: Do Adenovirus-Vector Vaccines Have Beneficial Non-Specific Effects?

Skip to first unread message

Wm. Stewart

May 4, 2022, 4:44:31 PMMay 4
to mrnad...@googlegroups.com

Here is some early and as yet non-corroborated data that the
adenovector-based vaccines may have greater benefits than mRNA
vaccines.  I share it not because it provides any definitive answers to
any important questions at this point, but because it is at least some
data about the comparative effects of mRNA vaccines and traditional
vaccines, and indicates paths that might be worth more investigation.

"In the randomized trials of the covid vaccines, the adenovector-based
vaccines, including the AstraZeneca and Johnson & Johnson vaccines,
reduced all-cause mortality of study participants relative to people
randomly assigned a placebo. Indeed, the reduction in mortality is
larger than expected from the Covid effect and may suggest additional
beneficial “non-specific effects” from those vaccines against other
health threats."


Actual study:



Reply all
Reply to author
0 new messages